Literature DB >> 9869568

Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp.

J A Upcroft1, R W Campbell, K Benakli, P Upcroft, P Vanelle.   

Abstract

The efficacies of 12 5-nitroimidazole compounds and 1 previously described lactam-substituted nitroimidazole with antiparasitic activity, synthesized via SRN1 and subsequent reactions, were assayed against the protozoan parasites Giardia duodenalis, Trichomonas vaginalis, and Entamoeba histolytica. Two metronidazole-sensitive lines and two metronidazole-resistant lines of Giardia and one line each of metronidazole-sensitive and -resistant Trichomonas were tested. All except one of the compounds were as effective or more effective than metronidazole against Giardia and Trichomonas, but none was as effective overall as the previously described 2-lactam-substituted 5-nitroimidazole. None of the compounds was markedly more effective than metronidazole against Entamoeba. Significant cross-resistance between most of the drugs tested and metronidazole was evident among metronidazole-resistant lines of Giardia and Trichomonas. However, some drugs were lethal to metronidazole-resistant Giardia and had minimum lethal concentrations similar to that of metronidazole for drug-susceptible parasites. This study emphasizes the potential in developing new nitroimidazole drugs which are more effective than metronidazole and which may prove to be useful clinical alternatives to metronidazole.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9869568      PMCID: PMC89023     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Induction of metronidazole and furazolidone resistance in Giardia.

Authors:  S M Townson; H Laqua; P Upcroft; P F Boreham; J A Upcroft
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Sep-Oct       Impact factor: 2.184

2.  Metronidazole in amoebic dysentery and amoebic liver abscess.

Authors:  S J Powell; I MacLeod; A J Wilmot; R Elsdon-Dew
Journal:  Lancet       Date:  1966-12-17       Impact factor: 79.321

3.  Metronidazole resistant Trichomonas vaginalis in Brisbane.

Authors:  T Voolmann; P Boreham
Journal:  Med J Aust       Date:  1993-10-04       Impact factor: 7.738

4.  Cryopreservation of viable Giardia intestinalis trophozoites.

Authors:  R E Phillips; P F Boreham; R W Shepherd
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

5.  Heterogeneity in the sensitivity of stocks and clones of Giardia to metronidazole and ornidazole.

Authors:  A C Majewska; W Kasprzak; J F De Jonckheere; E Kaczmarek
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Jan-Feb       Impact factor: 2.184

6.  Alternative 2-keto acid oxidoreductase activities in Trichomonas vaginalis.

Authors:  D M Brown; J A Upcroft; H N Dodd; N Chen; P Upcroft
Journal:  Mol Biochem Parasitol       Date:  1999-01-25       Impact factor: 1.759

7.  Clinical trials with metronidazole in human balantidiasis.

Authors:  A Garcia-Laverde; L de Bonilla
Journal:  Am J Trop Med Hyg       Date:  1975-09       Impact factor: 2.345

8.  Altered uptake of metronidazole in vitro by stocks of Giardia intestinalis with different drug sensitivities.

Authors:  P F Boreham; R E Phillips; R W Shepherd
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

9.  In vitro susceptibility of Giardia lamblia trophozoites to metronidazole and tinidazole.

Authors:  L Jokipii; A M Jokipii
Journal:  J Infect Dis       Date:  1980-03       Impact factor: 5.226

10.  Drug resistance and Giardia.

Authors:  J A Upcroft; P Upcroft
Journal:  Parasitol Today       Date:  1993-05
View more
  29 in total

1.  A new-generation 5-nitroimidazole can induce highly metronidazole-resistant Giardia lamblia in vitro.

Authors:  Linda A Dunn; Anita G Burgess; Kenia G Krauer; Lars Eckmann; Patrice Vanelle; Maxime D Crozet; Frances D Gillin; Peter Upcroft; Jacqueline A Upcroft
Journal:  Int J Antimicrob Agents       Date:  2010-04-24       Impact factor: 5.283

2.  Drug susceptibility testing of anaerobic protozoa.

Authors:  J A Upcroft; P Upcroft
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Amoebicidal activity of the rhizomes and aerial parts of Allium sivasicum on Entamoeba histolytica.

Authors:  S Degerli; S Berk; B Tepe; E Malatyali
Journal:  Parasitol Res       Date:  2012-01-04       Impact factor: 2.289

4.  Activity of picolinic acid in combination with the antiprotozoal drug quinacrine against Mycobacterium avium complex.

Authors:  Toshiaki Shimizu; Haruaki Tomioka
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 5.  Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.

Authors:  Vahab Ali; Tomoyoshi Nozaki
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

6.  5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis.

Authors:  Jacqueline A Upcroft; Linda A Dunn; Janelle M Wright; Kamel Benakli; Peter Upcroft; Patrice Vanelle
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

7.  In vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with Caco2 cells.

Authors:  Joachim Müller; Géraldine Rühle; Norbert Müller; Jean-François Rossignol; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

8.  A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities.

Authors:  Haris Mirza; Joshua D W Teo; Jacqui Upcroft; Kevin S W Tan
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

9.  Parasitic colitides.

Authors:  Joel E Goldberg
Journal:  Clin Colon Rectal Surg       Date:  2007-02

10.  The old and new therapeutic approaches to the treatment of giardiasis: where are we?

Authors:  Haendel G N O Busatti; Joseph F G Santos; Maria A Gomes
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.